Citation Tools
PDFRegular and young investigator award abstracts
Immuno-conjugates and chimeric molecules
631 Development of highly efficacious and safe targeted cancer immunotherapy via IL12-based TMEkine™ platform
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 631 Development of highly efficacious and safe targeted cancer immunotherapy via IL12-based TMEkine™ platform